ERBB2 and breast cancer: To confirm the clinical relevance of the suppression induced by the constructed immunoapoptotic molecules in HER‐2+ breast cancer, we subcutaneously injected SK‐BR‐3 cells into BALB/c nude mice to establish a breast cancer xenograft model.